These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23035262)

  • 1. [DGFIT: Immune and targeted therapy in urologic oncology – what can be expected?].
    Hegele A; Heinzer H; Rüttinger D; Siebels M
    Aktuelle Urol; 2012 Jul; 43(4):219-26. PubMed ID: 23035262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update uro-oncology: scientific meetings 2011].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genitourinary cancer.
    Hudes GR; Ozols RF; Schilder RJ
    Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bigot F; Bonnet C; Massard C
    Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses.
    Ogasawara M; Miyashita M; Ota S
    Ther Apher Dial; 2018 Jun; 22(3):266-277. PubMed ID: 29851270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open clinical uro-oncology trials in Canada.
    Mackenzie M; Rodrigues G; Winquist E
    Can J Urol; 2007 Aug; 14(4):3662-7. PubMed ID: 17784993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with combined cisplatin and radiation therapy for advanced urinary tract transitional cell carcinoma].
    Yoshioka T; Utsunomiya M; Itoh H; Itatani H; Namiki M
    Nihon Hinyokika Gakkai Zasshi; 1987 Mar; 78(3):518-24. PubMed ID: 3656856
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
    Shen J; Prentice M; Pollock Y; Franca M; Kanesvaran R
    J Geriatr Oncol; 2019 Jul; 10(4):523-525. PubMed ID: 30982753
    [No Abstract]   [Full Text] [Related]  

  • 10. Genitourinary cancer.
    Hudes GR; Grana G; Deshields MS; Ozols RF
    Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent advancement of the treatment of urological malignancies].
    Akaza H
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():157-64. PubMed ID: 10410670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urologic cancer in Thailand.
    Lojanapiwat B
    Jpn J Clin Oncol; 2015 Nov; 45(11):1007-15. PubMed ID: 26355159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma].
    Eisenhardt A; Ohlmann CH; Doehn C
    Urologe A; 2020 May; 59(5):533-543. PubMed ID: 32300817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential use of RNA interference as therapeutic strategy in urologic cancer.
    Green WJ; James PA; Ratan HL
    Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681
    [No Abstract]   [Full Text] [Related]  

  • 18. [The urological group of the EORTC (European Organization for Research on the Treatment of Cancer), 1976-1984].
    Smith PH; de Pauw M; Sylvester R
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():713-23. PubMed ID: 6543605
    [No Abstract]   [Full Text] [Related]  

  • 19. Latest progress in molecular biology and treatment in genitourinary tumours.
    González-Del-Alba A; Arranz JÁ; Bellmunt J; Maroto JP; Fernández-Calvo O; Valderrama BP; González-Billalabeitia E; Méndez-Vidal MJ; Cassinello J; Romero-Laorden N; Climent MÁ; Puente J; Peláez I; Lázaro-Quintela M; Gallardo E; Suárez C
    Clin Transl Oncol; 2020 Dec; 22(12):2175-2195. PubMed ID: 32440915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targetable gene fusions and aberrations in genitourinary oncology.
    Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
    Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.